Showing 1 - 20 results of 30,832 for search '(((( 50 ((a decrease) OR (_ decrease)) ) OR ( 150 point decrease ))) OR ( 12 men decrease ))*', query time: 0.80s Refine Results
  1. 1

    Mesothelin expression and RG7787 uptake is decreased in KLM-1-R. by Kevin Hollevoet (710450)

    Published 2015
    “…Uptake was evaluated at 30, 75 and 150 min. Average geomean fluorescence intensities converted into amount of RG7787 molecules.…”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Engineering of p150<sup>DNC-1</sup> mutants for functional characterization of dynactin's MT binding activity. by Daniel J. Barbosa (4288462)

    Published 2017
    “…The N-terminal region of the p150<sup>DNC-1</sup> subunit contains a conserved CAP-Gly domain (residues 1–69) predicted to bind the end-binding homology (EBH) domain of EB and the EEY/F motifs present at the C-termini of EB and α-tubulin. …”
  10. 10
  11. 11
  12. 12

    Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

    Published 2009
    “…<p>(A) RFF is decreased by alterations in heart rate. …”
  13. 13

    Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

    Published 2013
    “…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
  14. 14
  15. 15
  16. 16
  17. 17

    Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

    Published 2020
    “…<p>Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
  18. 18
  19. 19

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  20. 20